These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37758321)

  • 21. Chlorpromazine versus atypical antipsychotic drugs for schizophrenia.
    Saha KB; Bo L; Zhao S; Xia J; Sampson S; Zaman RU
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD010631. PubMed ID: 27045703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk Factors for Nonattendance in Delusional Infestation: A Multicenter Observational Study.
    Kemperman P; Wennekers M; Lepping P; Bewley A; Aboalkaz S; Kazmi A; Waalboer-Spuij R
    Dermatology; 2023; 239(1):116-121. PubMed ID: 35878589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New generation antipsychotics for first episode schizophrenia.
    Rummel C; Hamann J; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2003; (4):CD004410. PubMed ID: 14584012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delusional infestation: Clinical presentations, diagnosis, and management.
    Torales J; García O; Barrios I; O'Higgins M; Castaldelli-Maia JM; Ventriglio A; Jafferany M
    J Cosmet Dermatol; 2020 Dec; 19(12):3183-3188. PubMed ID: 33098221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.
    Dossenbach M; Pecenak J; Szulc A; Irimia V; Anders M; Logozar-Perkovic D; Peciukaitiene D; Kotler M; Smulevich AB; West TM; Lowry AJ; Treuer T
    J Clin Psychiatry; 2008 Dec; 69(12):1901-15. PubMed ID: 19012820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risperidone versus other atypical antipsychotic medication for schizophrenia.
    Gilbody SM; Bagnall AM; Duggan L; Tuunainen A
    Cochrane Database Syst Rev; 2000; (3):CD002306. PubMed ID: 10908551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delusional infestation in clinical practice over a period of two decades.
    Reszke R; Pacan P; Reich A; Szepietowski JC
    Postepy Dermatol Alergol; 2021 Feb; 38(2):144-150. PubMed ID: 34408581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study.
    Sikich L; Frazier JA; McClellan J; Findling RL; Vitiello B; Ritz L; Ambler D; Puglia M; Maloney AE; Michael E; De Jong S; Slifka K; Noyes N; Hlastala S; Pierson L; McNamara NK; Delporto-Bedoya D; Anderson R; Hamer RM; Lieberman JA
    Am J Psychiatry; 2008 Nov; 165(11):1420-31. PubMed ID: 18794207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delusional infestation in psychodermatology.
    Rosales Santillan M; Taylor DL; Reichenberg JS
    G Ital Dermatol Venereol; 2018 Aug; 153(4):497-505. PubMed ID: 29667798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse.
    Temmingh HS; Williams T; Siegfried N; Stein DJ
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011057. PubMed ID: 29355909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Switching patients with stable schizophrenia or schizoaffective disorder from olanzapine to risperidone long-acting injectable.
    Rosa F; Schreiner A; Thomas P; Sherif T
    Clin Drug Investig; 2012 Apr; 32(4):267-79. PubMed ID: 22339430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of olanzapine, risperidone, and haloperidol treatment on weight and body mass index in first-episode schizophrenia patients in India: a randomized, double-blind, controlled, prospective study.
    Saddichha S; Manjunatha N; Ameen S; Akhtar S
    J Clin Psychiatry; 2007 Nov; 68(11):1793-8. PubMed ID: 18052574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A retrospective comparison of weight, lipid, and glucose changes between risperidone- and olanzapine-treated inpatients: metabolic outcomes after 1 year.
    Meyer JM
    J Clin Psychiatry; 2002 May; 63(5):425-33. PubMed ID: 12019668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics.
    Faries D; Ascher-Svanum H; Zhu B; Correll C; Kane J
    BMC Psychiatry; 2005 May; 5():26. PubMed ID: 15921508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
    Yıldız M; Osman E
    Turk Psikiyatri Derg; 2022; 33(2):146-148. PubMed ID: 35730516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delusional infestation in dermatology in the UK: prevalence, treatment strategies, and feasibility of a randomized controlled trial.
    Lepping P; Baker C; Freudenmann RW
    Clin Exp Dermatol; 2010 Dec; 35(8):841-4. PubMed ID: 20184615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Diagnostic Workup, Screening, and Treatment Approaches for Patients with Delusional Infestation.
    Coetzee S; Mahajan C; França K
    Dermatol Ther (Heidelb); 2023 Dec; 13(12):2993-3006. PubMed ID: 37872445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 12-week randomized clinical trial to evaluate metabolic changes in drug-naive, first-episode psychosis patients treated with haloperidol, olanzapine, or risperidone.
    Perez-Iglesias R; Crespo-Facorro B; Amado JA; Garcia-Unzueta MT; Ramirez-Bonilla ML; Gonzalez-Blanch C; Martinez-Garcia O; Vazquez-Barquero JL
    J Clin Psychiatry; 2007 Nov; 68(11):1733-40. PubMed ID: 18052567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study.
    Bobes J; Garc A-Portilla MP; Rejas J; Hern Ndez G; Garcia-Garcia M; Rico-Villademoros F; Porras A
    J Sex Marital Ther; 2003; 29(2):125-47. PubMed ID: 12623765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Atypical antipsychotics and sexual dysfunction: five case-reports associated with risperidone].
    Haefliger T; Bonsack C
    Encephale; 2006; 32(1 Pt 1):97-105. PubMed ID: 16633296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.